Core Viewpoint - Axsome Therapeutics is collaborating with Mental Health America to raise awareness and promote action during Mental Health Month, highlighting the importance of mental health and the impact of mental health conditions in the U.S. [1][3] Company Overview - Axsome Therapeutics is a biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) disorders, aiming to improve the lives of individuals with serious conditions that are difficult to treat [4][7]. - The company has an industry-leading neuroscience portfolio that includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, along with multiple late-stage development programs targeting serious neurological and psychiatric conditions affecting over 150 million people in the U.S. [7] Mental Health Statistics - Nearly 1 in 4 adults in the U.S. live with a mental illness, and more than 1 in 8 individuals aged 12 or older reported feeling depressed in the past two weeks, indicating a significant prevalence of mental health issues [3]. - Approximately 90% of individuals living with depression experience difficulties in work, home, or social activities due to their symptoms, which complicates daily life [3] Advocacy and Resources - Axsome is promoting resources for individuals and communities to take action regarding mental health, including Mental Health America's Action Guide, online screening tools, youth leadership programs, and opportunities to become mental health advocates [4][6]. - The 988 Suicide & Crisis Lifeline is highlighted as a confidential support service available 24/7, connecting individuals in crisis with trained counselors [5].

Investment Rating - The report does not explicitly provide an investment rating for the mental health industry Core Insights - The mental health landscape shows a significant portion of adults in both the U.S. and Mexico rating their mental health positively, with approximately three-quarters assessing it as 'excellent' or 'good' [8][10] - There is a notable generational divide, with Gen Z and Millennials reporting lower self-rated mental health compared to older generations [8][13] - Mental health impacts work and personal relationships for about 30% of respondents, with U.S. Gen Z individuals being particularly affected [27][31] Summary by Sections Background & Methodology - The study conducted by ThinkNow involved a nationally representative sample of adults in the U.S. and Mexico, utilizing online surveys to gather data [3][4] Key Findings - Around 75% of adults in both countries rate their mental health positively, with U.S. Hispanics showing a slightly higher positive rating at 79% [10] - Self-care activities are practiced by about half of the respondents, with exercise being the most common, and other activities like meditation and journaling being more prevalent in the U.S. [8][41] - Accessibility to mental health services varies, with nearly 30% of U.S. respondents reporting a professional diagnosis of a mental health condition, compared to under 20% in Mexico [17][18] Detailed Findings - Gen Z and Millennials in the U.S. are more critical of their mental health than their Mexican counterparts, with significant differences in comfort levels discussing mental health with professionals [20][24] - The most common community resources available include counseling centers, online resources, and support groups, with crisis intervention services being less common in Mexico [48][50] Self-Care and Information Seeking - About half of respondents in both countries have engaged in self-care activities, with a higher engagement among younger generations [36][38] - Social media is a primary source of mental health information for Mexicans, while Americans are more likely to consult mental health websites and personal doctors [44][46]